Defining the Active Fraction of Daptomycin against Methicillin-Resistant Staphylococcus aureus (MRSA) Using a Pharmacokinetic and Pharmacodynamic Approach-Reference-Cited by-同舟云学术

Defining the Active Fraction of Daptomycin against Methicillin-Resistant Staphylococcus aureus (MRSA) Using a Pharmacokinetic and Pharmacodynamic Approach

Published:2016-06-10 Issue:6 Volume:11 Page:e0156131
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Garonzik Samira M.,Lenhard Justin R.,Forrest Alan,Holden Patricia N.,Bulitta Jϋrgen B.,Tsuji Brian T.

Funder

Foundation for the National Institutes of Health

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference26 articles.

1. The clinical relevance of protein binding and tissue concentrations in antimicrobial therapy;R Wise;Clinical pharmacokinetics,1986

2. Protein binding: do we ever learn?;MA Zeitlinger;Antimicrobial agents and chemotherapy,2011

3. Protein binding of antimicrobials: clinical pharmacokinetic and therapeutic implications;WA Craig;Clinical pharmacokinetics,1977

4. New insights into meticillin-resistant Staphylococcus aureus (MRSA) pathogenesis, treatment and resistance;IM Gould;International journal of antimicrobial agents,2012

5. Attenuated vancomycin bactericidal activity against Staphylococcus aureus hemB mutants expressing the small-colony-variant phenotype;BT Tsuji;Antimicrobial agents and chemotherapy,2008

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antimicrobial, Anti‐inflammatory, and Wound Healing Properties of Myrtus communis Leaf Methanolic Extract Ointment on Burn Wound Infection Induced by Methicillin‐Resistant Staphylococcus aureus in Rats;BioMed Research International;2024-01

2. Combatting the Rising Tide of Antimicrobial Resistance: Pharmacokinetic/Pharmacodynamic Dosing Strategies for Maximal Precision;International Journal of Antimicrobial Agents;2021-03

3. Clinical Pharmacokinetics of Daptomycin;Clinical Pharmacokinetics;2020-12-14

4. The Antistaphylococcal Lysin, CF-301, Activates Key Host Factors in Human Blood To Potentiate Methicillin-ResistantStaphylococcus aureusBacteriolysis;Antimicrobial Agents and Chemotherapy;2019-01-22

5. Antibiotics: Pharmacokinetics, toxicity, resistance and multidrug efflux pumps;Biochemical Pharmacology;2017-06